Trastuzumab Completed Phase 2 Trials for Stage IV Breast Cancer / Stage II Breast Cancer / Her2-Positive Breast Cancer / Stage IA Breast Cancer / Stage IIIC Breast Cancer / Stage IIIB Breast Cancer / Stage IB Breast Cancer / Stage IIIA Breast Cancer / Estrogen Receptor-Positive Breast Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01688609Lapatinib Ditosylate, Trastuzumab, Paclitaxel, and Surgery in Treating Patients With Breast Cancer
NCT00407888Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery